SUBJECTS : Cancer | Cancer-related Conditions | Solid Tumours | Haematologic Malignancie
Oncology and Therapy: 2023, vol: , issue:
- 1)- Olga Bodriagova, Rebecca Ann Previs, Lydia Gaba, Abhishek Shankar, Laura Vidal, Kamal S Saini. Recent Advances in Gynecological Malignancies: Focus on ASCO 2023. Oncology and therapy. 2023, 11 (4): 397-409
Cited : 0Read More - 2)- Brian Dong, Rita Lusen, Ella Chick, Lisa Kline. Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2- Metastatic Breast Cancer: A Podcast. Oncology and therapy. 2023, 11 (4): 411-418Cited : 0Read More
- 3)- Stephen V Liu, Ivy B Elkins, Jill Feldman, Sarah B Goldberg. EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)-A Podcast Discussion Between Patients and Oncologists. Oncology and therapy. 2023, 11 (4): 419-431Cited : 0Read More
- 4)- Reva Basho, Megan-Claire Chase. Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast. Oncology and therapy. 2023, 11 (4): 433-443Cited : 1Read More
- 5)- Hamdy A Azim, Samah A Loutfy, Hatem A Azim, Nermin S Kamal, Nasra F Abdel Fattah, Mostafa H Elberry, Mohamed R Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S Shohdy, Loay Kassem. The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer. Oncology and therapy. 2023, 11 (4): 445-459Cited : 2Read More
- 6)- Karthik Nagaraja Rao, Ripudaman Arora, Prajwal Dange, Nitin Nagarkar, Antti A Mäkitie, Luiz P Kowalski, Avraham Eisbruch, Marc Hamoir, Francisco J Civantos, Vincent Vander Poorten, Sweet Ping Ng, Sandra Nuyts, Mark Zafereo, Ameya A Asarkar, Paweł Golusinski, Ohad Ronen, Alfio Ferlito. A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers. Oncology and therapy. 2023, 11 (4): 461-480Cited : 5Read More
- 7)- Sandhya Mehta, Jipan Xie, Raluca Ionescu-Ittu, Xiaoyu Nie, Winghan J Kwong. Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer. Oncology and therapy. 2023, 11 (4): 481-493Cited : 0Read More
- 8)- Javier Sanchez Alvarez, Mahmoud Jaber, Marie-Hélène Blanchet Zumofen. Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma. Oncology and therapy. 2023, 11 (4): 495-511Cited : 0Read More
- 9)- Naama Halpern, Ben Boursi, Einat Shacham-Shmueli, Einav Nili Gal-Yam, Ofer Margalit, Talia Golan, Tamar Beller, Gal Strauss, Dafna Yahav, Eyal Leshem. Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer. Oncology and therapy. 2023, 11 (4): 513-519Cited : 0Read More
- 10)- Alex Filicevas, Thomas Powles. Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast. Oncology and therapy. 2023, 11 (3): 277-289Cited : 0Read More
- 11)- Trish Abbott, Kenrick Ng, Jenny Nobes, Paula Muehlschlegel. Small-Cell Carcinoma of the Prostate - Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece. Oncology and therapy. 2023, 11 (3): 291-301Cited : 0Read More
- 12)- Todd J Bixby, Christine J Brittle, Patricia A Mangan, Edward A Stadtmauer, Lisa R Kallenbach. Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews. Oncology and therapy. 2023, 11 (3): 303-312Cited : 3Read More
- 13)- Stephen Palmer, Yi Lin, Thomas G Martin, Sundar Jagannath, Andrzej Jakubowiak, Saad Z Usmani, Nasuh Buyukkaramikli, Hilary Phelps, Rafal Slowik, Feng Pan, Satish Valluri, Lida Pacaud, Graham Jackson. Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma. Oncology and therapy. 2023, 11 (3): 313-326Cited : 1Read More
- 14)- Duc Thanh Le, Lap Thanh Bui, Chu Van Nguyen, Kien Hung Do, Giang Le Tran, Tu Anh Do. Neoadjuvant Doxorubicin-Paclitaxel Combined Chemotherapy in Patients with Inoperable Stage III Breast Cancer: A Retrospective Cohort Study with 10 Years of Follow-Up in Vietnam. Oncology and therapy. 2023, 11 (3): 327-341Cited : 3Read More
- 15)- Jessie T Yan, Yue Jin, Ernest Lo, Yilin Chen, Amy E Hanlon Newell, Ying Kong, Landon J Inge. Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011-2021. Oncology and therapy. 2023, 11 (3): 343-360Cited : 4Read More
- 16)- Kai Conrad Cecil Johnson, Daniel Goldstein, Jasmin Tharakan, Dionisia Quiroga, Mahmoud Kassem, Michael Grimm, Abdul Miah, Craig Vargo, Michael Berger, Preeti Sudheendra, Ashley Pariser, Margaret E Gatti-Mays, Nicole Williams, Daniel Stover, Sagar Sardesai, Robert Wesolowski, Bhuvaneswari Ramaswamy, Gary Tozbikian, Patrick M Schnell, Mathew A Cherian. The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and therapy. 2023, 11 (3): 361-374Cited : 1Read More
- 17)- Andy Garnham, Franck Bruon, Céline Berthon, Delphine Lebon, Mounika Parimi, Rosalind Polya, Kahina M Makhloufi, Marie-Hélène Dramard-Goasdoue. French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study. Oncology and therapy. 2023, 11 (3): 375-389Cited : 0Read More
- 18)- Ferhan Guler, Nilay Yuksel, Seda Kahraman, Mehmet Ali Nahit Sendur. RETRACTED ARTICLE: Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors. Oncology and therapy. 2023, 11 (3): 391-396Cited : 1Read More
- 19)- Emine Eylem Genç, İrem Sena Saraç, Hayrunnisa Arslan, Ahmet Emre Eşkazan. Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial. Oncology and therapy. 2023, 11 (2): 145-152Cited : 0Read More
- 20)- Jay Kulsh. Biochemistry-Not Oncogenes-May Demystify and Defeat Cancer. Oncology and therapy. 2023, 11 (2): 153-169Cited : 0Read More
- 21)- Paulo Nunes Filho, Caroline Albuquerque, Mariana Pilon Capella, Marcio Debiasi. Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review. Oncology and therapy. 2023, 11 (2): 171-183Cited : 7Read More
- 22)- Shuwen Zheng, Yumei Feng, Chan Li, Jie Zhang, Ke Xie. Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma. Oncology and therapy. 2023, 11 (2): 185-198Cited : 3Read More
- 23)- D Soldato, L Arecco, E Agostinetto, M A Franzoi, E Mariamidze, S Begijanashvili, N Brunetti, S Spinaci, C Solinas, I Vaz-Luis, A Di Meglio, M Lambertini. The Future of Breast Cancer Research in the Survivorship Field. Oncology and therapy. 2023, 11 (2): 199-229Cited : 10Read More
- 24)- Danielle E Altman, Xinke Zhang, An-Chen Fu, Alissa R Rams, Jessica A Baldasaro, Samir Ali Ahmad, Michael Schlichting, Patrick Marquis, Elena Benincasa, Camilo Moulin, Vivek Pawar. Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study. Oncology and therapy. 2023, 11 (2): 231-244Cited : 4Read More
- 25)- Dana Chase, Jessica Perhanidis, Divya Gupta, Linda Kalilani, Amanda Golembesky, Antonio González-Martín. Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance. Oncology and therapy. 2023, 11 (2): 245-261Cited : 7Read More
- 26)- Sundar Jagannath, Nedra Joseph, Concetta Crivera, Akshay Kharat, Carolyn C Jackson, Satish Valluri, Patricia Cost, Hilary Phelps, Rafal Slowik, Timothy Klein, Lee Smolen, Xueting Yu, Adam D Cohen. Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma. Oncology and therapy. 2023, 11 (2): 263-275Cited : 9Read More
- 27)- Ohad Ronen, K Thomas Robbins, Ashok R Shaha, Luiz P Kowalski, Antti A Mäkitie, Ewa Florek, Alfio Ferlito. Emerging Concepts Impacting Head and Neck Cancer Surgery Morbidity. Oncology and therapy. 2023, 11 (1): 1-13Cited : 2Read More
- 28)- Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic. Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy. 2023, 11 (1): 111-128Cited : 3Read More
- 29)- Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano. A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy. 2023, 11 (1): 129-143Cited : 3Read More
- 30)- Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari. Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy. 2023, 11 (1): 15-24Cited : 3Read More
- 31)- Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari. Correction: Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy. 2023, 11 (1): 25Cited : 0Read More
- 32)- Eleanor Allison, Senarath Edirimanne, Jim Matthews, Stephen J Fuller. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis. Oncology and therapy. 2023, 11 (1): 27-48Cited : 29Read More
- 33)- Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev. Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy. 2023, 11 (1): 49-64Cited : 4Read More
- 34)- Peter Borchmann, Jan-Michel Heger, Jörg Mahlich, Michael S Papadimitrious, Sybille Riou, Barbara Werner. Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis. Oncology and therapy. 2023, 11 (1): 65-81Cited : 2Read More
- 35)- Adrián Alegre, Gonzalo Benzo, Rafael Alonso, Joaquín Martínez-López, Ana Jimenez-Ubieto, Clara Cuéllar, Elham Askari, Elena Prieto, Concepción Aláez, Beatriz Aguado, Alberto Velasco, Isabel Krsnik, Ana Bocanegra, Laura Llorente, Cristina Muñoz-Linares, Ana Morales, Eugenio Giménez, Rebeca Iglesias, Carmen Martínez-Chamorro, Aránzazu Alonso, Carmen Jiménez-Montes, María J Blanchard, . Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP). Oncology and therapy. 2023, 11 (1): 83-96Cited : 9Read More
- 36)- Cecilie Ejerskov, Stense Farholt, Flemming Secher Kromann Nielsen, Ingunn Berg, Stine Bogetofte Thomasen, Aparna Udupi, Trude Ågesen, Sofie de Fine Licht, Mette Møller Handrup. Clinical Characteristics and Management of Children and Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas in Denmark: A Nationwide Study. Oncology and therapy. 2023, 11 (1): 97-110Cited : 4Read More
- 37)- Zodwa Dlamini, Thulo Molefi, Richard Khanyile, Mahlori Mkhabele, Botle Damane, Alexandre Kokoua, Meshack Bida, Kamal S Saini, Nkhensani Chauke-Malinga, Thifhelimbilu Emmanuel Luvhengo, Rodney Hull. From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa. Oncology and therapy. 2023, : Cited : 2Read More
- 38)- Heidi Ko, Rebecca A Previs, Kyle C Strickland, Jonathan Klein, Brian Caveney, Chiara Chiruzzi, Marcia Eisenberg, Eric A Severson, Shakti Ramkissoon, Kamal S Saini. Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate? Oncology and therapy. 2023, : Cited : 0Read More
- 39)- Giulio Metro, Eleonora Gariazzo, Silvia Costabile, Sara Baglivo, Fausto Roila, Francesca Colamartini, Barbara Palumbo, Pietro Chiarini, Stefania Gori, Antonio Conti, Luca Marcomigni, Guido Bellezza, Gianluigi Lunardi. Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer. Oncology and therapy. 2023, : Cited : 1Read More
- 40)- Elisa Agostinetto, Luca Arecco, Evandro de Azambuja. Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely? Oncology and therapy. 2023, : Cited : 3Read More
- 41)- Pauline Frank, Anne Olshan, Tracey Iraca, Cindy Anthony, Sophie Wintrich, Emma Sasse. Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK. Oncology and therapy. 2023, : Cited : 1Read More
- 42)- Dany Habr, Manmohan Singh, Roberto Uehara. Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia. Oncology and therapy. 2023, : Cited : 1Read More
- 43)- Hong Chen, Yan Wen, Yun Zeng, Lie Lin, Bihong Sun, Hongqian Zhu, Huiqing He, Xiaotao Wang, Waiyi Zou, Caifeng Zheng, Liling Zheng, Jinxiong Huang, Liping Pang, Jixian Huang, Yuming Zhang, Haiqing Lin, Zelin Liu, Wanshou Zhu, Qiang Wang, Xuan Zhou, Xiaoli Liu, Hong Qu, Zhenfang Liu, Xin Du, Na Xu. Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors. Oncology and therapy. 2023, : Cited : 0Read More
- 44)- Giuseppe Di Lorenzo, Aieta Michele, Leo Silvana, Domenico Bilancia, Rossella Di Trolio, Michela Rosaria Iuliucci, Concetta Ingenito, Roberta Rubino, Arianna Piscosquito, Michele Caraglia, Marianna Donnarumma, Ferdinando Costabile, Raffaele Conca, Marco Pisino, Angelo Vaia, Luca Scafuri, Antonio Verde, Carlo Buonerba. A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario. Oncology and therapy. 2023, : Cited : 1Read More
